Frey O, Kamradt T
Institut für Immunologie, Universitätsklinikum Jena, Leutragraben 3, 07743 Jena.
Ophthalmologe. 2011 Jan;108(1):7-12. doi: 10.1007/s00347-010-2255-z.
Biologics and especially therapeutic monoclonal antibodies have an ever increasing impact in the therapy of inflammatory and malignant diseases. They allow a selective blockade of cytokines, receptors and other molecules. This review summarizes the immunological background, the current state and future trends in the development of these therapeutic agents.
生物制剂,尤其是治疗性单克隆抗体,在炎症性疾病和恶性疾病的治疗中发挥着越来越大的作用。它们能够选择性地阻断细胞因子、受体和其他分子。本综述总结了这些治疗药物的免疫学背景、当前状况及未来发展趋势。